XML 65 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurement - Narrative (Details)
$ in Thousands
Dec. 31, 2022
USD ($)
security
May 24, 2022
USD ($)
Fair Value Disclosures [Abstract]    
Number of securities in unrealized loss position | security 20  
Securities in continuous unrealized loss position, less than 12 months $ 117,200  
Securities in continuous unrealized loss position, less than 12 months, accumulated loss 900  
Antares Pharma, Inc    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Contingent consideration, liability $ 15,700 $ 130,000